{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ALNT",
  "name": "Allient Inc.",
  "url": "https://frontierpicks.com/dossiers/ALNT/",
  "json_url": "https://frontierpicks.com/dossiers/ALNT.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Record-orders story intact — Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M — but the supply picture changed after the note: the CEO's trusts sold 70,000 shares at $112.49–$115.765 on 2026-08-10 and 13D holder Juniper sold 165,991 shares into 2026-08-13. Narrative now maturing, with nothing dated to test it until the ~November Q3 print.",
  "invalidation_trigger": "A weekly close below $96 round-trips the entire post-print re-rating (shares first traded to $96.02 on the 2026-08-05 report); secondary, a Q3 2026 book-to-bill under 1.0x or backlog printing below $298.0M.",
  "catalyst_date": "2026-08-19",
  "outcome": "INVALIDATED",
  "outcome_date": "2026-08-24",
  "invalidation_fired": true,
  "themes": [
    "cyclical-industrials",
    "physical-ai-robotics",
    "critical-materials-rare-earths"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Fiscal year is the calendar year: Q2 2026 is the June quarter, released 2026-08-05 with the call on 2026-08-06.",
    "Quarterly dividend $0.04/share, record date 2026-08-19, payable 2026-09-02 — raised from the $0.03 paid 2026-04-03.",
    "Some data feeds and historical earnings pages still index the company under its former name, Allied Motion Technologies (AMOT).",
    "CEO Richard S. Warzala reported 1,489,106 shares owned after the 2026-08-10 transactions, so insider ownership stays concentrated in one holder.",
    "Six sell-side analysts cover the name; aggregator consensus targets lag individual updates and can print far below the latest published target."
  ],
  "body_markdown": "## Current Thesis\n\nThe fundamental leg is unchanged from the 2026-08-05 report: orders of $201.3M (+49% YoY), a 1.31x book-to-bill, backlog of $298.0M against $236.6M a year earlier, and a record 34.9% gross margin. What has changed in the week since is the identity of the seller. A Form 4 filed 2026-08-12 shows CEO Richard S. A day later, a Schedule 13D/A dated 2026-08-13 disclosed that Juniper Targeted Opportunity Fund sold 165,991 shares between 2026-08-11 and 2026-08-13 for approximately $18,792,719 aggregate, leaving the Juniper reporting persons at 596,314 shares, about 3.5% of outstanding. The order inflection and the distribution are both real and both dated.\n\n## Bull Case\n\n- **Orders $201.3M in Q2 2026, +49% YoY; book-to-bill 1.31x; backlog $298.0M vs $236.6M at Q2 2025 quarter end** (Q2 2026 results release, 2026-08-05). The order break follows two flat revenue years.\n- **Revenue $153.770M vs $145.685M consensus; adjusted EPS $0.80 vs $0.61 consensus** (Benzinga recap, 2026-08-05). GAAP net income $10.4M / $0.61 diluted, +85% YoY; adjusted EBITDA $23.7M, 15.4% of revenue.\n- **Gross margin 34.9%, +170bp YoY**, called a record in the release and attributed to volume, mix and internal efficiency work. Operating margin 10.2%.\n- **JP Morgan raised its target twice in 25 days** — to $95 from $80 on 2026-07-13, then to $120 from $95 on 2026-08-07, maintaining Overweight. Estimate revisions are still moving up, not down.\n- **Balance sheet leaves room**: cash $42.1M, total debt $173.3M, leverage 1.63x at Q2 2026 quarter end, with management having flagged acquisition monitoring after deleveraging.\n- The dividend was stepped up to $0.04 per share (record 2026-08-19) from the $0.03 paid 2026-04-03.\n\n## Bear Case\n\n- **The largest insider and a 13D holder both sold into the high.** CEO trust sales at $112.49–$115.765 on 2026-08-10 (Form 4, 2026-08-12) and 165,991 Juniper shares for ~$18,792,719 through 2026-08-13 (13D/A) landed within pennies of the $114.28 52-week high. Ownership remains large — but the marginal supply now has a name.\n- **Cash conversion is negative.** Free cash flow was -$18.31M in Q2 2026 versus +$22.38M in Q2 2025, on higher receivables and inventory. The order build is financed through working capital.\n- **One quarter proves nothing about a cycle.** A single 1.31x book-to-bill against a two-year flat revenue base is a data point; the $298.0M backlog has yet to convert.\n- **Rare-earth exposure is disclosed and unresolved.** On the Q2 2025 call management said $3–4M of revenue was pulled forward on customer concern about heavy rare earth constraints.\n- **Restructuring costs tied to the Dothan transition are still running through the P&L** (Q2 2026 release).\n- **Sell-side coverage is thin and stale.** Aggregator summaries dated 2026-08-12 show six covering analysts, four buy / two hold, with trailing average targets in the $76–$84 range — most have not refreshed since the print, so the $120 from JP Morgan is close to the only published number above spot.\n\n## Setup & Price Structure\n\n**The narrative is maturing.** Dating it: the headline flow stopped on 2026-08-07 (JP Morgan's $120), the 52-week high of $114.28 was set in the following sessions, and the two filings that hit the tape afterwards — the 2026-08-12 Form 4 and the 2026-08-13 13D/A — were supply, not new narrative. The last completed daily close, 2026-08-14, was $111.41, 2.5% under that high, with RSI(14) at 73.7 against 75.5 on 2026-08-07. The story is well known and still working; the incremental bid is no longer arriving with fresh headlines. That band is the origin of the move. The three-month return is 81.8%. Since 2026-08-07 the price has held a narrow range beneath $114.28 without giving back the gap, which is a consolidation too short to call a shelf.\n\n**Crowding and positioning observables**, stated as observables: RSI 73.7 after an 81.8% three-month advance; price within 2.5% of an all-time-area high; a 13D holder reduced to ~3.5%; no company-dated event between the 2026-09-02 dividend payment and the Q3 print expected in early November.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-09-02** — Dividend payment date. Cash leaves the balance sheet in a quarter that followed -$18.31M free cash flow.\n- **Ongoing, any date** — Further Form 4 or 13D/A amendments. Juniper's stake is now ~3.5%; additional sales, or a stop, are filed and visible within two business days.\n- **~2026-11-04 (est.), outside the 30-day window** — Q3 2026 results and call. Q2 cadence was release 2026-08-05, call 2026-08-06. This is the first genuine test of the thesis and nothing before it is comparable in weight.\n\n## Elapsed catalysts\n\n- **2026-08-19** — Record date, $0.04 quarterly dividend. Confirms the step-up from $0.03; a capital-allocation marker, it resolves nothing about backlog conversion. *(passed 7d ago)*\n\n## What Would Change Our Mind\n\nThe structural break is the post-print gap. Shares moved from a $93.25 grant reference on 2026-08-05 to $114.28 in four sessions; that move is what the record-orders quarter bought, and losing it undoes the argument. A weekly close below $96 round-trips it entirely, with the $96.02 first print on the 2026-08-05 report as the reference. Ahead of that, a daily close that fails to hold the low $100s would mark the first crack in an otherwise untested consolidation.\n\nOn fundamentals, the thesis breaks if the Q3 2026 release shows book-to-bill under 1.0x or backlog below $298.0M — either would recast the 49% order jump as pull-forward. A second consecutive quarter of negative free cash flow with leverage rising from 1.63x would break the deleveraging leg independently of price. Conversely, a Q3 book-to-bill again above 1.0x with backlog above $298.0M and free cash flow back positive would re-date the narrative as accelerating rather than maturing.\n\n## Correlation Notes\n\n- Revenue is spread across industrial automation, vehicle, medical and aerospace/defense end markets, so the order book tracks small-cap industrial capex rather than any single secular theme; the name trades with the small-cap industrial complex and the Russell 2000, not with semis.\n- Permanent-magnet motors tie the input cost line to heavy rare earth availability — the same constraint management quantified as a $3–4M revenue pull-forward on the Q2 2025 call. Chinese export-control headlines move the whole motion-control group together.\n- The company reports organic constant-currency growth separately from reported growth, so euro and other non-dollar translation is a visible swing factor between the two lines.",
  "first_seen": "2026-08-07",
  "last_analyzed": "2026-08-16T17:07:09+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}